Fig. 2From: Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysisOverall survival (OS). A < 4 weeks vs. 4–6 weeks. B < 4 weeks vs. > 6 weeks. C > 6 weeks vs. 4–6 weeksBack to article page